BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34571136)

  • 1. Thioridazine reverts the phenotype in cellular and Drosophila models of amyotrophic lateral sclerosis by enhancing TDP-43 aggregate clearance.
    Cragnaz L; Spinelli G; De Conti L; Bureau EA; Brownlees J; Feiguin F; Romano V; Skoko N; Klima R; Kettleborough CA; Baralle FE; Baralle M
    Neurobiol Dis; 2021 Dec; 160():105515. PubMed ID: 34571136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals.
    Tamaki Y; Shodai A; Morimura T; Hikiami R; Minamiyama S; Ayaki T; Tooyama I; Furukawa Y; Takahashi R; Urushitani M
    Sci Rep; 2018 Apr; 8(1):6030. PubMed ID: 29662239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
    Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
    Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
    Hergesheimer RC; Chami AA; de Assis DR; Vourc'h P; Andres CR; Corcia P; Lanznaster D; Blasco H
    Brain; 2019 May; 142(5):1176-1194. PubMed ID: 30938443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models.
    Droppelmann CA; Campos-Melo D; Noches V; McLellan C; Szabla R; Lyons TA; Amzil H; Withers B; Kaplanis B; Sonkar KS; Simon A; Buratti E; Junop M; Kramer JM; Strong MJ
    Brain; 2024 Jun; 147(6):2053-2068. PubMed ID: 38739752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP.
    Cheng CW; Lin MJ; Shen CK
    J Neurogenet; 2015; 29(2-3):59-68. PubMed ID: 26219309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
    Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
    J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model.
    Cragnaz L; Klima R; De Conti L; Romano G; Feiguin F; Buratti E; Baralle M; Baralle FE
    Neuroscience; 2015 Dec; 311():415-21. PubMed ID: 26518462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.
    Cicardi ME; Cristofani R; Rusmini P; Meroni M; Ferrari V; Vezzoli G; Tedesco B; Piccolella M; Messi E; Galbiati M; Boncoraglio A; Carra S; Crippa V; Poletti A
    Sci Rep; 2018 Aug; 8(1):12390. PubMed ID: 30120266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
    Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor neuron expression of the voltage-gated calcium channel cacophony restores locomotion defects in a Drosophila, TDP-43 loss of function model of ALS.
    Chang JC; Hazelett DJ; Stewart JA; Morton DB
    Brain Res; 2014 Oct; 1584():39-51. PubMed ID: 24275199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy.
    Khalil B; Chhangani D; Wren MC; Smith CL; Lee JH; Li X; Puttinger C; Tsai CW; Fortin G; Morderer D; Gao J; Liu F; Lim CK; Chen J; Chou CC; Croft CL; Gleixner AM; Donnelly CJ; Golde TE; Petrucelli L; Oskarsson B; Dickson DW; Zhang K; Shorter J; Yoshimura SH; Barmada SJ; Rincon-Limas DE; Rossoll W
    Mol Neurodegener; 2022 Dec; 17(1):80. PubMed ID: 36482422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation.
    Chen Y; Cohen TJ
    J Biol Chem; 2019 Mar; 294(10):3696-3706. PubMed ID: 30630951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy.
    Cascella R; Fani G; Capitini C; Rusmini P; Poletti A; Cecchi C; Chiti F
    FASEB J; 2017 Dec; 31(12):5609-5624. PubMed ID: 28842427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of Ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly.
    Jantrapirom S; Lo Piccolo L; Yoshida H; Yamaguchi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3038-3049. PubMed ID: 29936333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions.
    Watanabe R; Higashi S; Nonaka T; Kawakami I; Oshima K; Niizato K; Akiyama H; Yoshida M; Hasegawa M; Arai T
    Acta Neuropathol Commun; 2020 Oct; 8(1):176. PubMed ID: 33115537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Riku Y
    Neuropathology; 2020 Oct; 40(5):426-435. PubMed ID: 32157757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A robust TDP-43 knock-in mouse model of ALS.
    Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.
    Watabe K; Kato Y; Sakuma M; Murata M; Niida-Kawaguchi M; Takemura T; Hanagata N; Tada M; Kakita A; Shibata N
    Neuropathology; 2020 Dec; 40(6):570-586. PubMed ID: 32686212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
    Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
    Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.